Medtronic Side Effects

Report Medtronic Side Effects

If you experienced any harmful or unwanted effects of Medtronic, please share your experience. This could help to raise awareness about Medtronic side effects, identify uknown risks and inform health professionals and patients taking Medtronic.

Examples: headache, dizziness

The most commonly reported Medtronic side effects are:
Headaches (1 reports)
Irregular Heartbeat (1 reports)
Seizure (1 reports)
Severe Rash (1 reports)

If you have experienced a side effect listed above, you can check a box to report it.

To view a complete list of submitted side effects, please follow the link Medtronic side effects . You can also compare Medtronic side effects or view FDA reports.

Medtronic Side Effects reported to FDA

The following Medtronic reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Medtronic on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Cardiac Perforation, Medical Device Complication, Product Quality Issue
on May 16, 2013 Female from US , 74 years of age, weighting 130.0 lb, was treated with Medtronic 5086 Mri Leads. Directly after, patient experienced the unwanted or unexpected Medtronic side effects: cardiac perforation, medical device complication, product quality issue. Medtronic 5086 Mri Leads dosage: N/A. Patient was hospitalized and became disabled.

Cardiac Valve Replacement Complication, Heart Valve Incompetence
Patient was taking Medtronic Mosaic Porcine Heart Valve. Patient felt the following Medtronic side effects: cardiac valve replacement complication, heart valve incompetence on Jul 08, 2008 from UNITED STATES Additional patient health information: Male , 84 years of age, weighting 194.4 lb, . Medtronic Mosaic Porcine Heart Valve dosage: N/A.

Anoxic Encephalopathy, Cardio-respiratory Arrest, Coronary Artery Occlusion, Coronary Artery Thrombosis, Post Procedural Complication, Stent Occlusion
Adverse event was reported on Apr 17, 2008 by a Male taking Medtronic Endeavor Stent (Dosage: N/A) . Location: UNITED STATES , 59 years of age, weighting 268.0 lb, After Medtronic was administered, patient encountered several Medtronic side effects: anoxic encephalopathy, cardio-respiratory arrest, coronary artery occlusion, coronary artery thrombosis, post procedural complication, stent occlusion. Patient was hospitalized and became disabled.

Failure Of Implant, Hypoaesthesia, Pain
on Jan 17, 2007 Female from UNITED STATES , 35 years of age, weighting 165.0 lb, was diagnosed with and was treated with Medtronic Premier Plate. Directly after, patient experienced the unwanted or unexpected Medtronic side effects: failure of implant, hypoaesthesia, pain. Medtronic Premier Plate dosage: N/A. Patient was hospitalized and became disabled.

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Medtronic

Find Out How to Take Medtronic

Discuss Medtronic Side Effects

Did You Have a Medtronic Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor

How Effective is Medtronic for You?

Exceeded Expectations
Somewhat Effective
Not Effective

Safety Alerts, Active Ingredients, Usage Information

More About Medtronic

Side Effects reported to FDA: 4

Medtronic safety alerts: 2014 2013 2012 2011 2009 2008 2007 2006 2005 2004

Reported deaths: 1

Reported hospitalizations: 1

Medtronic Drug Infusion Pumps: Recall - Intermittent or Permanent Pump Motor Stall

SynchroMed II Implantable
SynchroMed EL Implantable


AUDIENCE: Risk Manager, Physical Medicine, Neurosurgery

ISSUE: FDA and Medtronic notified healthcare professionals that using unapproved drugs with the SynchroMed Infusion Pump may negatively impact the pump’s performance. The use of unapproved drugs can lead to intermittent or permanent pump motor stall and cessation of drug infusion. A cessation of drug infusion may cause serious adverse health consequences, including death.

BACKGROUND: The SynchroMed II and SynchroMed EL Implantable Drug Infusion Pumps contain and administer prescribed drugs or fluids to a specific site inside the patient’s body. Currently, the approved drugs for use with the SynchroMed Infusion Pump are Infumorp, Lioresal, Prialt (Ziconotide), Floxuridine, Methotrexate and Gablofen.

These infusion pumps were manufactured from May 1998 through November 2012 and distributed from April 1999 through November 2012. Model numbers can be found in the recall notice.

RECOMMENDATION: To minimize the potential for motor stall, the firm recommended that healthcare professionals only use the approved drugs that are identified in the SynchroMed Infusion Pump labeling or drugs approved by FDA that are labeled for use with the SynchroMed II pump. Do not use compounded drugs, unapproved concentrations, or unapproved formulations with the SynchroMed Infusion Pump

Refer to the Medtronic Medical Device Safety Notification disclaimer icon , sent November 9, 2012 to healthcare professionals, which includes detailed information about this issue. In addition to the Healthcare Professional Letter, the safety notification provided a white paper documenting the Increased Risk of Motor Stall and Loss of or Change in Therapy when Unapproved Drug Formulations are used with the SynchroMed Pump and a summary of the drugs that are approved to be used with the SynchroMed.

[12/21/2012 - Recall Notice - FDA]
[11/09/2012 - Safety Notification disclaimer icon - Medtronic]

Latest Medtronic clinical trials